Related Experiment Video
Updated: Jul 15, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
Large Language Models to Extract Cancer Staging Data From Clinical Documentation at Scale
Swapna Abhyankar1, Rajesh M Rao1, Mehraveh Salehi1
1Truveta, Inc, Bellevue, WA.
Purpose:
To develop a large language model (LLM) (Truveta Language Model Oncology [TLM-Oncology]) to extract real-world oncology staging data across multiple cancer types from clinical documentation with high precision.
Methods:
We selected patients from a large integrated health system with a bladder, cervical, colorectal, breast, or prostate cancer diagnosis in their structured data. We identified relevant notes using note metadata and keywords and annotated overall stage; T, N, and M; associated timeframe; and cancer diagnosis on a sample of 700 notes as ground truth. Of the 700 notes, 450 were divided equally between training, validation, and test sets for bladder, cervical, and colorectal cancers; 150 were used for targeted error-pattern training on these cancers; and the remaining 100 were split equally between breast and prostate cancer test sets. We started with a pretrained LLM and applied supervised fine-tuning to adapt the model to structured clinical information extraction. Model performance was measured using precision, recall, and F1 scores at the relation level and individual attribute level.
Results:
We extracted over 2.5 million staging records for 217,768 patients from over two million notes. Relation-level precision across the six attributes ranged from 0.77 to 1.0 for the first three cancers and, without further training, 0.83 to 1.0 for two additional cancers.
Conclusion:
TLM-Oncology extracted detailed cancer staging information for five cancers from a variety of clinical documentation within a single integrated health system with high precision and turned data that were previously inaccessible into a valuable resource for downstream use. We are currently evaluating TLM-Oncology on other solid tumors within three additional health systems to assess its generalizability.